Table of Content

1 Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2 Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study

3 Executive Summary

4 Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Declining Costs of Sequencing
4.2.2. Increasing Prevalence of Cancer and Genetic Disorders
4.2.3. Growing Utilization of NGS in Disease Diagnostics and Precision Medicine
4.2.4. Rising R&D Investments and Healthcare Expenditures
4.3. Restraints
4.3.1. Availability of Alternative Technologies
4.3.2. Low Chances of Identifying Positive Actionable Mutations for Precision Medicine
4.4. Opportunities
4.4.1. Increasing Applications of Next-generation Sequencing Technology
4.4.2. Collaborations Between Vendors to Develop Automated Library Preparation Protocols
4.5. Challenges
4.5.1. Regulatory and Standardization Concerns in Diagnostic Testing
4.5.2. Limited Expertise and Sequencing Capabilities of Small & Mid-sized Laboratories
4.6. The Impact of COVID-19 on the Global NGS Library Preparation Market
4.7. Related/Adjacent Markets
4.7.1. NGS Automation Market
4.8. Technological Trends

5 Global NGS Library Preparation Market, by Product
5.1. Introduction
5.2. Reagents & Consumables
5.2.1. Library Preparation Kits
5.2.1.1. DNA Library Preparation Kits
5.2.1.2. RNA Library Preparation Kits
5.2.2. Other Reagents & Consumables
5.3. Instruments/Workstations

6 Global NGS Library Preparation Market, by Sequencing Type
6.1. Introduction
6.2. Targeted Genome Sequencing
6.3. Whole Genome Sequencing
6.4. Whole Exome Sequencing
6.5. Other Sequencing Types

7 Global NGS Library Preparation Market, by Application
7.1. Introduction
7.2. Disease Diagnostics
7.2.1. Reproductive Health Diagnostics
7.2.2. Cancer Diagnostics
7.2.3. Infectious Disease Diagnostics
7.2.4. Other Disease Diagnostics
7.3. Drug Discovery
7.4. Other Applications

8 Global NGS Library Preparation Market, by End User
8.1. Introduction
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic Institutes & Research Centers
8.5. Other End Users

9 NGS Library Preparation Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa

10 Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2022)
10.4.1. Illumina, Inc. (U.S.)
10.4.2. Thermo Fisher Scientific, Inc. (U.S.)
10.4.3. F. Hoffmann-La Roche Ltd (Switzerland)
10.4.4. Agilent Technologies, Inc. (U.S.)

11 Company Profiles
11.1. Illumina, Inc.
11.2. Thermo Fisher Scientific, Inc.
11.3. F. Hoffmann-La Roche Ltd
11.4. PerkinElmer Inc.
11.5. QIAGEN N.V.
11.6. Agilent Technologies, Inc.
11.7. Tecan Group Ltd.
11.8. Pacific Biosciences of California, Inc.
11.9. Danaher Corporation
11.10. New England Biolabs, Inc.
11.11. Merck KGaA
11.12. Diagenode S.A. (A Subsidiary of Hologic, Inc.)

12 Appendix
12.1. Questionnaire
12.2. Available Customization



List of Figures

Figure 1 Research Process

Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global NGS Library Preparation Market Size, by Product, 2023 Vs 2030 (USD Million)
Figure 8 Global NGS Library Preparation Market Size, by Sequencing Type, 2023 Vs 2030 (USD Million)
Figure 9 Global NGS Library Preparation Market Size, by Application, 2023 Vs 2030 (USD Million)
Figure 10 Global NGS Library Preparation Market Size, by End User, 2023 Vs 2030 (USD Million)
Figure 11 NGS Library Preparation Market Size, by Geography
Figure 12 Market Dynamics
Figure 13 Genome Sequencing Costs (2010–2021)
Figure 14 Pharmaceutical R&D Expenditures in the U.S., Europe, and China, 2010 Vs. 2019 Vs. 2020 (USD Million)
Figure 15 Global Biopharmaceutical R&D Expenditure, 2016–2028 (USD Billion)
Figure 16 Global NGS Automation Market Scenario
Figure 17 Global NGS Library Preparation Market Size, by Product, 2023 Vs 2030 (USD Million)
Figure 18 Global NGS Library Preparation Market Size, by Sequencing Type, 2023 Vs 2030 (USD Million)
Figure 19 Global NGS Library Preparation Market Size, by Application, 2023 Vs 2030 (USD Million)
Figure 20 Estimated Number of New Cancer Cases (In Million)
Figure 21 U.S.: New Molecular Entity (NME) Approvals
Figure 22 Global NGS Library Preparation Market Size, by End User, 2023 Vs 2030 (USD Million)
Figure 23 Global NGS Library Preparation Market Size, by Region, 2023 Vs. 2030 (USD Million)
Figure 24 North America: NGS Library Preparation Market Snapshot
Figure 25 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 26 Europe: Pharmaceutical R&D Expenditure, 2000–2020 (USD Million)
Figure 27 Europe: NGS Library Preparation Market Snapshot
Figure 28 Italy: Number of Biotechnology Firms, 2010 Vs. 2015 Vs. 2020
Figure 29 RoE: Pharmaceutical R&D Expenditure, 2020
Figure 30 Asia-Pacific: NGS Library Preparation Market Snapshot
Figure 31 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 32 NGS Library Preparation Market: Competitive Benchmarking Based on Product
Figure 33 NGS Library Preparation Market: Competitive Benchmarking Based on Geography
Figure 34 Market Share Analysis: NGS Library Preparation Market (2022)
Figure 35 Illumina, Inc.: Financial Overview (2021)
Figure 36 Thermo Fisher Scientific, Inc.: Financial Overview (2021)
Figure 37 F. Hoffmann-La Roche Ltd.: Financial Overview (2021)
Figure 38 PerkinElmer Inc.: Financial Overview (2021)
Figure 39 QIAGEN N.V.: Financial Overview, 2021
Figure 40 Agilent Technologies, Inc.: Financial Overview (2021)
Figure 41 Tecan Group Ltd.: Financial Overview (2021)
Figure 42 Pacific Biosciences of California, Inc.: Financial Overview (2021)
Figure 43 Danaher Corporation: Financial Overview (2021)
Figure 44 Merck KGaA: Financial Overview (2021)
Figure 45 Hologic, Inc.: Financial Overview (2021)